Treatment of psoriasis with ustekinumab in a patient with HIV-related Kaposi sarcoma

Clin Exp Dermatol. 2019 Jan;44(1):113-115. doi: 10.1111/ced.13630. Epub 2018 May 24.

Authors

D M Wang¹, A P Fernandez², C M Calabrese³, L H Calabrese³

Affiliations

¹ School of Medicine, Case Western Reserve University, Cleveland, OH, USA.
² Departments of Dermatology and Pathology, Cleveland Clinic Foundation, Cleveland, OH, USA.
³ Department of Rheumatic and Immunological Diseases, Cleveland Clinic Foundation, Cleveland, OH, USA.

PMID: 29797733
DOI: 10.1111/ced.13630

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Dermatologic Agents / therapeutic use
HIV / isolation & purification
HIV Infections / complications
HIV Infections / drug therapy*
HIV Infections / pathology
Humans
Interleukin-12 / antagonists & inhibitors
Interleukin-23 / antagonists & inhibitors
Male
Middle Aged
Psoriasis / drug therapy*
Psoriasis / pathology
Sarcoma, Kaposi / complications*
Sarcoma, Kaposi / drug therapy
Sarcoma, Kaposi / pathology
Sarcoma, Kaposi / virology
Treatment Outcome
Ustekinumab / administration & dosage
Ustekinumab / therapeutic use*
Viral Load / drug effects

Substances

Antibodies, Monoclonal, Humanized
Dermatologic Agents
Interleukin-23
Interleukin-12
Ustekinumab